ICLR241018P310000
- 26.88
- -0.22-0.81%
Icon PLC Newsroom
Should You Be Adding ICON (NASDAQ:ICLR) To Your Watchlist Today?
Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting)
ICON Plc Schedules Third Quarter 2024 Earnings Conference Call
Medpace, Fortrea Cut as Jefferies Reviews CROs Amid Biotech Headwinds
Here's How Much $100 Invested In Icon 10 Years Ago Would Be Worth Today
Baird Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $340
Express News | Baird Maintains Outperform on Icon, Lowers Price Target to $340
Express News | ICON PLC : Baird Cuts Target Price to $340 From $368
ICON Draws Bullish View at Leerink on Business Model
Icon Initiated at Outperform by Leerink Partners
Icon Price Target Announced at $379.00/Share by Leerink Partners
Leerink Partners Initiates Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $379
Express News | ICON PLC : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $379
Implied Volatility Surging for ICON (ICLR) Stock Options
Here's Why ICON (NASDAQ:ICLR) Can Manage Its Debt Responsibly
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
Icon PLC (ICLR) Surges 3.3%: Is This an Indication of Further Gains?
ICON Shares Rebound as Analysts Say Selloff Is Overdone
Icon Price Target Maintained With a $368.00/Share by Baird
Icon Is Maintained at Outperform by Baird